Abstract
Occasional cannabis use has been associated with increased antiretroviral therapy (ART) adherence and relief of HIV symptoms, while heavy use has been associated with low ART adherence and negative psychological symptoms. The purpose of the present study was to investigate differences between non-cannabis use (NC), non-dependent cannabis use (C), and dependent use (CD) in terms of ART adherence and HIV symptoms/ART side effects. A cross-sectional sample of 180 HIV+ individuals (78.3 % male) completed measures of substance use and psychopathology, medication adherence, and HIV symptoms/ART side effects. Adherence was also measured via pill count, viral load, and CD4 count. Results indicated that the CD group reported lower adherence and greater HIV symptoms/ART side effects than the other two groups, with no differences observed between NC and C groups. There is a clinical need to address dependent cannabis use among those prescribed ART. Further examination is needed to ascertain the functions of cannabis use among individuals with HIV.
Similar content being viewed by others
Notes
Thirteen participants were excluded from analyses involving pill count adherence due to inability to calculate pill counts.
As absolute CD4 count and viral load have been associated with disease progression (Mellors et al., 1997; Viana et al., 2011), analyses were repeated with both absolute CD4 count and log viral load serving as additional covariates in the ANCOVA model. With these additional covariates, the significant effect for group in terms of HIV symptoms/medication side effects, remained [F(2,155) = 3.26, p = 0.041].
References
Abrams, D. I., Jay, C. A., Shade, S. B., Vizoso, H., Reda, H., Press, S., et al. (2007). Cannabis in painful HIV-associated sensory neuropathy. Neurology, 68(7), 515–521. doi:10.1212/01.wnl.0000253187.66183.9c
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th Ed.—Text Revision). Washington, DC: American Psychiatric Association.
Amico, K. R., Simoni, J. M., & Pantalone, D. W. (2012). Enhancing antiretroviral adherence: A 2012 update. In J. A. Trafton & W. Gordon (Eds.), Best practices in the behavioral management of chronic disease, Volume 2: Other medical disorders. Los Altos, Ca: Institute for Brain Potential.
Ammassari, A., Murri, R., Pezzotti, P., Trotta, M. P., Ravasio, L., De Longis, P., et al. (2001). Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. Journal of Acquired Immune Deficiency Syndromes, 28(5), 445–449. doi:10.1097/00126334-200112150-00006
Babor, T. F., Higgins-Biddle, J. C., Saunders, J. B., & Monteiro, M. G. (1992). AUDIT: The alcohol use disorders identification test (2nd ed.). Geneva, Switzerland: World Health Organization, Department of Mental Health and Substance Dependence.
Bangsberg, D. R., Kroetz, D. L., & Deeks, S. G. (2007). Adherence-resistance relationships to combination HIV antiretroviral therapy. Current HIV/AIDS Report, 4(2), 65–72. doi:10.1007/s11904-007-0010-0
Bangsberg, D. R., Perry, S., Charlebois, E. D., Edwin, D., Clark, R. A., Roberston, M., et al. (2001). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS, 15(9), 1181–1183. doi:10.1097/00002030-200106150-00015
Belle-Isle, L., & Hathaway, A. (2007). Barriers to access to medical cannabis for Canadians living with HIV/AIDS. AIDS Care, 19, 500–506. doi:10.1080/09540120701207833
Beusterien, K. M., Davis, E. A., Flood, R., Howard, K., & Jordan, J. (2008). HIV patient insight on adhering to medication: A qualitative analysis. AIDS Care, 20, 251–259. doi:10.1080/09540120701487666
Bonn-Miller, M. O., & Zvolensky, M. J. (2009). An evaluation of the nature of marijuana use and its motives among young adult active users. American Journal on Addictions, 18(5), 409–416. doi:10.1080/10550490903077705
Bonn-Miller, M. O., Zvolensky, M. J., & Bernstein, A. (2007). Marijuana use motives: Concurrent relations to frequency of past 30-day use and anxiety sensitivity among young adult marijuana smokers. Addictive Behaviors, 32, 49–62. doi:10.1016/j.addbeh.2006.03.018
Bonolo, P. F., Machado, C. J., Cesar, C. C., Ceccato, M. G., & Guimaraes, M. D. (2008). Vulnerability and non-adherence to antiretroviral therapy among HIV patients, Minas Gerais State, Brazil. Cadernos de Saúde Pública, 24(11), 2603–2613. doi:10.1590/S0102-311X2008001100015
Brown, R. A., Lejuez, C. W., Kahler, C. W., & Strong, D. R. (2002). Distress tolerance and duration of past smoking cessation attempts. Journal of Abnormal Psychology, 111(1), 180–185. doi:10.1037//0021-843X.111.1.180
Budney, A. J., Hughes, J. R., Moore, B. A., & Vandrey, R. (2004). Review of the validity and significance of cannabis withdrawal syndrome. American Journal of Psychiatry, 161, 1967–1977. doi:10.1176/appi.ajp.161.11.1967
Centers for Disease Control and Prevention. (2012) Cases of HIV infection and AIDS in the United States and dependent areas. HIV/AIDS surveillance report, 17. Available at http://www.cdc.gov/hiv/stats/hasrlink.htm
Chesney, M. (2003). Adherence to HAART regimens. AIDS Patient Care and STDs, 17, 169–177. doi:10.1089/108729103321619773
Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS Care, 12(3), 255–266. doi:10.1080/09540120050042891
Corless, I. B., Lindgren, T., Holzemer, W., Robinson, L., Moezzi, S., Kirksey, K., et al. (2009). Marijuana effectiveness as an HIV self-care strategy. Clinical Nursing Research, 18(2), 172–193. doi:10.1177/1054773809334958
Cristiani, S. A., Pukay-Martin, N. D., & Bornstein, R. A. (2004). Marijuana use and cognitive function in HIV-infected people. Journal of Neuropsychiatry and Clinical Neurosciences, 16, 330–335. doi:10.1176/appi.neuropsych.16.3.330
Crum, N. F., Riffenburgh, R. H., Wegner, S., Agan, B., Tasker, S. A., Spooner, K. M., et al. (2006). Comparisons of causes of death and mortality rates among HIV-infected persons: Analysis of the pre-, early and late HAART (highly active antiretroviral therapy) eras. Journal of Acquired Immune Deficiency Syndromes, 41, 194–200. doi:10.1097/01.qai.0000179459.31562.16
Das, M., Chu, P., Santos, G. M., Scheer, S., Vittinghoff, E., McFarland, W., et al. (2010). Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS ONE, 5(6), e11068. doi:10.1371/journal.pone.0011068
de Jong, B. C., Prentiss, D., McFarland, W., Machekano, R., & Israelski, D. M. (2005). Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea. Journal of Acquired Immune Deficiency Syndromes, 38, 43–46. doi:10.1097/00126334-200501010-00008
First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1995). Structured clinical interview for DSM-IV Axis I disorders-non-patient edition. New York: New York State Psychiatric Institute.
Fogarty, A., Rawstorne, P., Prestage, G., Crawford, J., Grierson, J., & Kippax, S. (2007). Marijuana as therapy for people living with HIV/AIDS: Social and health aspects. AIDS Care, 19, 295–307. doi:10.1080/09540120600841930
French, T., Tesoriero, J., & Agins, B. (2011). Changes in stress, substance use and medication beliefs are associated with changes in adherence to HIV antiretroviral therapy. AIDS and Behavior, 15(7), 1416–1428. doi:10.1007/s10461-010-9762-4
Friedman, M. S., Marshal, M. P., Stall, R., Kidder, D. P., Henny, K. D., Courtenay-Quirk, C., et al. (2009). Associations between substance use, sexual risk taking and HIV treatment adherence among homeless people living with HIV. AIDS Care, 21(6), 692–700. doi:10.1080/09540120802513709
Furler, M. D., Einarson, T. R., Millson, M., Walmsley, S., & Bendayan, R. (2004). Medicinal and recreational marijuana use by patients infected with HIV. AIDS Patient Care and STDs, 18(4), 215–228. doi:10.1089/108729104323038892
Gandhi, R. T., & Deeks, S. G. (2012). Plasma HIV-1 RNA levels during antiretroviral therapy: How low is low enough? Clinical Infectious Diseases, 54(5), 733–735. doi:10.1093/cid/cir933
Gifford, A. L., Bormann, J. E., Shively, M. J., Wright, B. C., & Richman, D. D. (2000). Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. Journal of Acquired Immune Deficiency Syndromes, 23, 386–395. doi:10.1097/00126334-200004150-00005
Grant, B. F., & Pickering, R. (1998). The relationship between cannabis use and DSM-IV cannabis abuse and dependence: Results from the National Longitudinal Alcohol Epidemiologic Survey. Journal of Substance Abuse, 10, 255–264. doi:10.1016/S0899-3289(99)00006-1
Haney, M., Gunderson, E. W., Rabkin, J., Hart, C. L., Vosburg, S. K., Comer, S. D., et al. (2007). Dronabinol and marijuana in HIV-positive marijuana smokers: Caloric intake, mood and sleep. Journal of Acquired Immune Deficiency Syndromes, 45(5), 545–554. doi:10.1097/QAI.0b013e31811ed205
Haubrich, R. H., Little, S. J., Currier, J. S., Forthal, D. N., Carol, A., Beall, G. N., et al. (1999). The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS, 13(9), 1099–1107. doi:10.1097/00002030-199906180-00014
Hogg, R. S., Heath, K. V., Bangsberg, D., Yip, B., Press, N., O’Shaughnessy, M. V., et al. (2002). Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS, 16(7), 1051–1058. doi:10.1097/00002030-200205030-00012
Hosek, S. G., Harper, G. W., & Domanico, R. (2005). Predictors of medication adherence among HIV-infected youth. Psychology, Health, & Medicine, 10, 166–179. doi:10.1080/1354350042000326584
Ironson, G. (2005). Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosomatic Medicine, 67(6), 1013–1021. doi:10.1097/01.psy.0000188569.58998.c8
James, A. C., Warner, L. A., & Kessler, R. C. (1994). Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey. Experimental and Clinical Psychopharmacology, 2(3), 244–268.
Kalichman, S. C., Amaral, C. M., White, D., Swetsze, C., Kalichman, M. O., Cherry, C., et al. (2012). Alcohol and adherence to antiretroviral medications: Interactive toxicity beliefs among people living with HIV. Journal of the Association of Nurses in AIDS Care. [Epub ahead of print] doi:10.1016/j.jana.2011.11.005
Kandel, D., Chen, K., Warner, L. A., Kessler, R. C., & Grant, B. (1997). Prevalence and demographic correlates of symptoms of last year dependence on alcohol, nicotine, marijuana and cocaine in the U.S. population. Drug and Alcohol Dependence, 44(1), 11–29. doi:10.1016/S0376-8716(96)01315-4
Kleeberger, C. A., Phair, J. P., Srathdee, S. A., Detels, R., Kingsley, L., & Jacobson, L. P. (2001). Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study. Journal of Acquired Immune Deficiency Syndrome, 26, 82–92. doi:10.1097/00126334-200101010-00012
Low-Beer, S., Yip, B., O’Shaughnessy, M. V., Hogg, R. S., & Montaner, J. S. (2000). Adherence to triple therapy and viral load response. Journal of Acquired Immune Deficiency Syndromes, 23, 360–361. doi:10.1097/00126334-200004010-00016
Machtinger, E. & Bansberg, D. (2012) Adherence to HIV antiretroviral therapy. HIV InSite Knowledge Base Chapter, UCSF. Retrieved from http://hivinsite.ucsf.edu/InSite?page=kb-03-02-09
Mellors, J. W., Munoz, A., Giorgi, J. V., Margolick, J. B., Tassoni, C. J., Gupta, P., et al. (1997). Plasma viral load and CD4 + lymphocytes as prognostic markers of HIV-1 infection. Annals of Internal Medicine, 126(12), 946–954.
Mocroft, A., Ledergerber, B., Katlama, C., Kirk, O., Reiss, P., d’Arminio Monforte, A., et al. (2003). Decline in the AIDS and death rates in the EuroSIDA study: An observational study. The Lancet, 362(9377), 22–29. doi:10.1016/S0140-6736(03)13802-0
Murphy, D. A., Marelich, W. D., Hoffman, D., & Steers, W. N. (2004). Predictors of antiretroviral adherence. AIDS Care, 16(4), 471–484. doi:10.1080/09540120410001683402
Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of Medicine, 353, 487–497.
Parienti, J., Bangsberg, D., Verdon, R., & Gardner, E. (2009). Better adherence with once-daily antiretroviral regimens: A meta-analysis. Clinical Infectious Diseases, 48(4), 484–488. doi:10.1086/596482
Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133(1), 21–30.
Prentiss, D., Power, R., Balmas, G., Tzuang, G., & Israelski, D. (2004). Patterns of marijuana use among patients with HIV/AIDS followed in a public health setting. Journal of Acquired Immune Deficiency Syndromes, 35, 38–45. doi:10.1097/00126334-200401010-00005
Saunders, J. B., Aasland, O. G., Babor, T. F., de la Fuente, J. R., & Grant, M. (1993). Development of the Alcohol Use Disorders Screening Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction, 88, 791–804. doi:10.1111/j.1360-0443.1993.tb02093.x
Shuter, J., & Bernstein, S. L. (2008). Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy. Nicotine & Tobacco Research, 10(4), 731–736. doi:10.1080/14622200801908190
Simoni, J. M., Kurth, A. E., Pearson, C. R., Pantalone, D. W., Merrill, J. O., & Frick, P. A. (2006). Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS Behavior, 10(3), 227–245. doi:10.1007/s10461-006-9078-6
Solomon, T. M., & Halkitis, P. N. (2008). Cognitive executive functioning in relation to HIV medication adherence among gay, bisexual, and other men who have sex with men. AIDS Behavior, 12(1), 68–77. doi:10.1007/s10461-007-9273-0
Stephens, R. S., Roffman, R. A., Roger, A., Fearer, S. A., Williams, C., & Burke, R. S. (2007). The marijuana check-up: Promoting change in ambivalent marijuana users. Addiction, 102(6), 947–957. doi:10.1111/j.1360-0443.2007.01821.x
Substance Abuse and Mental Health Services Administration. (2011). Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings (NSDUH Series H-41, HHS Publication No. [SMA] 11-4658). Rockville, MD.
Tucker, J. S., Burnam, M. A., Sherbourne, C. D., Kung, F.-Y., & Gifford, A. L. (2003). Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infections. American Journal of Medicine, 114, 573–580. doi:10.1016/S0002-9343(03)00093-7
U.S. Department of Health and Human Services, Clinical Guidelines Portal. (2012) Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Retrieved from http://aidsinfo.nih.gov/guidelines
U.S. Health Resources and Services Administration. (2012) Health resources and services administration HIV/AIDS Bureau. Retrieved from http://hab.hrsa.gov/deliverhivaidscare/clinicalguide11/cg-104_hrsa_indicators.html
Viana, G. M. D. C., Nascimento, M. D. S. B., Ferreira, A. M., Rabelo, E. M. F., Neto, J. A. D., Galvao, C. S., et al. (2011). Evaluation of laboratory markers of progression of HIV disease to death. Revista da Sociedade Brasileira de Medicina Tropical, 44(6), 657–660. doi:10.1590/S0037-86822011005000062
Wagner, G., & Miller, L. G. (2004). Is the influence of social desirability on patients’ self-reported adherence overrated? Journal of Acquired Immune Deficiency Syndromes, 35(2), 203–204. doi:10.1097/00126334-200402010-00016
Wilson, K. J., Doxanakis, A., & Fairley, C. K. (2004). Predictors for non-adherence to antiretroviral therapy. Sexual Health, 1, 251–257. doi:10.1071/SH04020
Wood, E., Hogg, R. S., Yip, B., Harrigan, R. P., O’Shaughnessy, M. V., & Montaner, J. S. G. (2004). The impact of adherence on CD4 cell count responses among HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes, 35(3), 261–268. doi:10.1097/00126334-200403010-00006
Woolridge, E., Barton, S., Samuel, J., Osorio, J., Dougherty, A., & Holdcroft, A. (2005). Cannabis use in HIV for pain and other medical symptoms. Journal of Pain and Symptom Management, 29, 358–367. doi:10.1016/j.jpainsymman.2004.07.011
Zvolensky, M. J., Bonn-Miller, M. O., Leyro, T., Johnson, K., & Bernstein, A. (2010). Marijuana: An overview of the empirical literature. In B. Johnson (Ed.), Addiction medicine: Science and practice (Vol. 1, pp. 445–461). New York: Springer.
Zvolensky, M. J., Lejuez, C. W., Kahler, C. W., & Brown, R. A. (2004). Nonclinical panic attack history and smoking cessation: An initial examination. Addictive Behaviors, 29(4), 825–830. doi:10.1016/j.addbeh.2004.02.017
Zvolensky, M. J., Lewinsohn, P., Bernstein, A., Schmidt, N. B., Buckner, J. D., Seeley, J., et al. (2008). Prospective associations between cannabis use, abuse, dependence and panic attacks and disorder. Journal of Psychiatric Research, 42(12), 1017–1023. doi:10.1016/j.jpsychires.2007.10.012
Acknowledgments
This work was supported by a California HIV/AIDS Research Program IDEA Award (163836) as well as a VA Clinical Science Research and Development (CSR&D) Career Development Award—2, awarded to Dr. Bonn-Miller. Additional support for this project was provided by VA Health Services Research and Development Service Funds for Dr. Oser. The expressed views do not necessarily represent those of the Department of Veterans Affairs. The authors would like to thank Neha Mitragotri, Nicole Short, Jessica Galang, and Cecily Reber for their assistance in data collection, Dr. Karen Relucio for recruitment and data collection support, NCIRE staff at SFVA for providing space, and the Immune Clinic at VA Palo Alto for their recruitment support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bonn-Miller, M.O., Oser, M.L., Bucossi, M.M. et al. Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms. J Behav Med 37, 1–10 (2014). https://doi.org/10.1007/s10865-012-9458-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10865-012-9458-5